The Lancet HIV Editor Peter Hayward talks to Evgeny Krupitsky about a trial investigating the potential of slow-release naltrexone to improve HIV treatment adherence in drug users in St Petersburg.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet HIV Editor Peter Hayward talks to Evgeny Krupitsky about a trial investigating the potential of slow-release naltrexone to improve HIV treatment adherence in drug users in St Petersburg.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv